Einar S Björnsson

Summary

Affiliation: Landspitali University Hospital
Country: Iceland

Publications

  1. pmc Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting
    Jóhann P Hreinsson
    Department of Internal Medicine, The National University Hospital of Iceland, Section of Gastroenterology and Hepatology, Reykjavik, Iceland
    Scand J Gastroenterol 48:439-47. 2013
  2. ncbi Use of statins in patients with liver disease
    E Kalaitzakis
    Department of Gastroenterology Skåne University Hospital University of Lund, Lund, Sweden
    Minerva Gastroenterol Dietol 60:15-24. 2014
  3. doi Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland
    Einar S Björnsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, National University Hospital, Reykjavik, Iceland
    Gastroenterology 144:1419-25, 1425.e1-3; quiz e19-20. 2013
  4. doi Drug-induced cholestasis
    Einar S Björnsson
    Division of Gastroenterology and Hepatology, The National University Hospital of Iceland, Hringbraut 101, Reykjavik, Iceland
    Clin Liver Dis 17:191-209. 2013
  5. pmc Clinical trial: marine lipid suppositories as laxatives
    Orri Thor Ormarsson
    Department of Pediatric Surgery, Children s Hospital, Landspitali University Hospital, 101 Reykjavik, Iceland
    Mar Drugs 10:2047-54. 2012
  6. ncbi Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland
    J Hepatol 56:374-80. 2012
  7. ncbi Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis
    Einar Bjornsson
    Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland
    Clin Gastroenterol Hepatol 9:57-63. 2011
  8. ncbi Drug-induced autoimmune hepatitis: clinical characteristics and prognosis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland
    Hepatology 51:2040-8. 2010
  9. doi Review article: drug-induced liver injury in clinical practice
    E Bjornsson
    Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland
    Aliment Pharmacol Ther 32:3-13. 2010
  10. doi Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy
    Einar Bjornsson
    Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Ther 18:198-205. 2011

Collaborators

Detail Information

Publications30

  1. pmc Upper gastrointestinal bleeding: incidence, etiology and outcomes in a population-based setting
    Jóhann P Hreinsson
    Department of Internal Medicine, The National University Hospital of Iceland, Section of Gastroenterology and Hepatology, Reykjavik, Iceland
    Scand J Gastroenterol 48:439-47. 2013
    ..The authors aimed to investigate the incidence and outcomes of acute upper gastrointestinal bleeding (AUGIB) and to examine the role of drugs potentially associated with AUGIB...
  2. ncbi Use of statins in patients with liver disease
    E Kalaitzakis
    Department of Gastroenterology Skåne University Hospital University of Lund, Lund, Sweden
    Minerva Gastroenterol Dietol 60:15-24. 2014
    ..Statin therapy seems to be related to a reduced risk for hepatocellular carcinoma in patients with chronic liver disease, but randomized data are lacking. ..
  3. doi Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland
    Einar S Björnsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, National University Hospital, Reykjavik, Iceland
    Gastroenterology 144:1419-25, 1425.e1-3; quiz e19-20. 2013
    ..Little is known about the incidence of drug-induced liver injury (DILI) in the general population. We investigated the incidence and the quantitative risk of DILI in a population-based cohort...
  4. doi Drug-induced cholestasis
    Einar S Björnsson
    Division of Gastroenterology and Hepatology, The National University Hospital of Iceland, Hringbraut 101, Reykjavik, Iceland
    Clin Liver Dis 17:191-209. 2013
    ..Most cases of cholestatic DILI are mild, but in rare cases, ductopenia and cholestatic cirrhosis can develop. Approximately 10% of patients with cholestatic jaundice caused by drugs develop liver failure...
  5. pmc Clinical trial: marine lipid suppositories as laxatives
    Orri Thor Ormarsson
    Department of Pediatric Surgery, Children s Hospital, Landspitali University Hospital, 101 Reykjavik, Iceland
    Mar Drugs 10:2047-54. 2012
    ....
  6. ncbi Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland
    J Hepatol 56:374-80. 2012
    ..Limited data exist on drug-induced liver injury (DILI) associated with statins...
  7. ncbi Patients with typical laboratory features of autoimmune hepatitis rarely need a liver biopsy for diagnosis
    Einar Bjornsson
    Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland
    Clin Gastroenterol Hepatol 9:57-63. 2011
    ..The importance of histologic analysis of biopsy samples in the diagnosis and management of patients with autoimmune hepatitis (AIH) is unclear...
  8. ncbi Drug-induced autoimmune hepatitis: clinical characteristics and prognosis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland
    Hepatology 51:2040-8. 2010
    ..Discontinuation of immunosuppression was tried and successful in 14 DIAIH cases, with no relapses (0%), whereas 65% of the AIH patients had a relapse after discontinuation of immunosuppression (P < 0.0001)...
  9. doi Review article: drug-induced liver injury in clinical practice
    E Bjornsson
    Department of Internal Medicine, Landspitali University Hospital, Reykjavik, Iceland
    Aliment Pharmacol Ther 32:3-13. 2010
    ..Drug-induced liver injury (DILI) is an important differential diagnosis in many patients in clinical hepatology. DILI is the leading cause of acute liver failure and is an important safety issue when new drugs are developed...
  10. doi Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy
    Einar Bjornsson
    Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Ther 18:198-205. 2011
    ..Most patients had a good biochemical response to steroids, but adverse effects were common. Future work should be directed at finding therapy that is more effective, better tolerated, and of more lasting benefit...
  11. ncbi [Drug-induced liver injury]
    Einar S Björnsson
    Laeknabladid 96:175-82. 2010
    ..In patients with a high clinical suspicion of DILI the causative drug need to be discontinued and patients with jaundice and/or coagulopathy have to be hospitalized and some cases considered for a liver transplantation...
  12. ncbi Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension
    Steingerdur Anna Gunnarsdottir
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Goteborg, Sweden
    Am J Gastroenterol 98:1362-70. 2003
    ..Our aim was to explore the relationship between motility abnormalities, portal hypertension, and SIBO...
  13. pmc Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
    Iris Posserud
    Department of Internal Medicine, Sahlgrenska University Hospital, 41345 Goteborg, Sweden
    Gut 56:802-8. 2007
    ..Small intestinal bacterial overgrowth (SIBO) has been proposed to be common in irritable bowel syndrome (IBS), with altered small-bowel motility as a possible predisposing factor...
  14. doi Effects on gastrointestinal transit and antroduodenojejunal manometry after gut-directed hypnotherapy in irritable bowel syndrome (IBS)
    Perjohan Lindfors
    Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Scand J Gastroenterol 47:1480-7. 2012
    ..In this study we aimed to investigate the effects on gastrointestinal motility when treating IBS with gut-directed hypnotherapy...
  15. ncbi Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors
    Magnus Simren
    Department of Internal Medicine and Section of Psychiatry, Institute of Clinical Neuroscience, Sahlgrenska University Hospital, Goteborg, Sweden
    Am J Gastroenterol 97:389-96. 2002
    ..Symptoms compatible with irritable bowel syndrome (IBS) are common in IBD patients in remission. The importance of psychological factors in this process is a matter of controversy...
  16. doi Impact of dialysis on gastroesophageal reflux, dyspepsia, and proton pump inhibitor treatment in patients with chronic renal failure
    Hans Strid
    Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Eur J Gastroenterol Hepatol 21:137-42. 2009
    ....
  17. ncbi Impaired gastrocolonic response and peristaltic reflex in slow-transit constipation: role of 5-HT(3) pathways
    Einar S Björnsson
    Division of Gastroenterology, Department of Internal Medicine, Sahlgrenska University Hospital, S 41345 Gothenburg, Sweden
    Am J Physiol Gastrointest Liver Physiol 283:G400-7. 2002
    ..Thus abnormalities of neural reflex modulation of colonic motor function may play pathophysiological roles in slow-transit constipation...
  18. doi Lower gastrointestinal bleeding: incidence, etiology, and outcomes in a population-based setting
    Jóhann P Hreinsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, National University Hospital, Reykjavik, Iceland
    Eur J Gastroenterol Hepatol 25:37-43. 2013
    ..To investigate the incidence and outcomes of acute lower gastrointestinal bleeding (ALGIB) in a population-based setting and examine the role of drugs potentially associated with GIB...
  19. doi Paracetamol intoxications: a retrospective population-based study in Iceland
    Ingibjörg Kjartansdottir
    Faculty of Public Health, University of Iceland, Reykjavik, Iceland
    Scand J Gastroenterol 47:1344-52. 2012
    ..The authors analyzed the population-based annual incidence of paracetamol overdoses and ALF, and described the risk factors for hepatotoxicity...
  20. ncbi Acute pancreatitis: a prospective study on incidence, etiology, and outcome
    Hanna Vidarsdottir
    aDepartment of Anaesthesia and Intensive Care bDepartment of Surgery cDepartment of Gastroenterology, The National University Hospital of Iceland dFaculty of Medicine, University of Iceland, Reykjavik, Iceland eDepartment of Surgery, Helsingborg Hospital, Helsingborg, Sweden
    Eur J Gastroenterol Hepatol 25:1068-75. 2013
    ..Alcohol consumption has increased considerably in Iceland during the last decade. We aimed to determine the incidence, etiology, severity, and complications of AP and compare the results with a previous study on AP in Iceland...
  21. ncbi Lipid-induced colonic hypersensitivity in the irritable bowel syndrome: the role of bowel habit, sex, and psychologic factors
    Magnus Simren
    Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Clin Gastroenterol Hepatol 5:201-8. 2007
    ..Duodenal lipid infusion increases colonic hypersensitivity in irritable bowel syndrome (IBS). Whether this is affected by bowel habit, psychologic factors, or sex is unknown...
  22. ncbi Patients with chronic renal failure have abnormal small intestinal motility and a high prevalence of small intestinal bacterial overgrowth
    Hans Strid
    Department of Internal Medicine, Boras Hospital, Boras, Sweden
    Digestion 67:129-37. 2003
    ..Our aims were to assess gastric and small intestinal motility and the prevalence of small intestinal bacterial overgrowth (SIBO) in order to clarify possible pathophysiological mechanisms behind these symptoms in CRF patients...
  23. ncbi The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study
    Theodora R Baldursdottir
    Department of aGastroenterology and Hepatology, The National University Hospital of Iceland, University of Iceland, Reykjavik, Iceland
    Eur J Gastroenterol Hepatol 24:824-30. 2012
    ..Very few population-based studies exist on the epidemiology of primary biliary cirrhosis (PBC), and none have been conducted in the last decade. We aimed to determine the epidemiology and prognosis of PBC over the past two decades...
  24. doi Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome
    Perjohan Lindfors
    Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Scand J Gastroenterol 47:414-20. 2012
    ..This retrospective study aims to evaluate the long-term perceived efficacy of gut-directed hypnotherapy given outside highly specialized hypnotherapy centers...
  25. ncbi Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome
    Magnus Simren
    Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Psychosom Med 66:233-8. 2004
    ..Postprandial symptoms in irritable bowel syndrome are common and relate to an exaggerated motor and sensory component of the gastrocolonic response. We investigated whether this response can be affected by hypnotherapy...
  26. doi Jaundice due to suspected statin hepatotoxicity: a case series
    Ottar M Bergmann
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital of Iceland, Reykjavik, Iceland
    Dig Dis Sci 57:1959-64. 2012
    ....
  27. ncbi Characteristics, prognosis and outcome of patients with oesophageal varices in a university hospital in Sweden 1994-1999
    Steingerdur Anna Gunnarsdottir
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 40:1462-8. 2005
    ..Patients with liver cirrhosis, portal hypertension and oesophageal varices are known to have high morbidity and mortality. The knowledge of incidence, aetiology and outcome in Sweden in recent years is limited...
  28. ncbi Health-related quality of life in patients attending a gastroenterology outpatient clinic: functional disorders versus organic diseases
    Magnus Simren
    Department of Internal Medicine, Institute of Clinical Neuroscience, Sahlgrenska University Hospital, S 41345 Goteborg, Sweden
    Clin Gastroenterol Hepatol 4:187-95. 2006
    ..This study aimed to compare HRQOL between these 2 groups and to assess factors of importance for HRQOL...
  29. ncbi The risk of colorectal cancer after an attack of uncomplicated diverticulitis
    Bjarki T Alexandersson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland
    Scand J Gastroenterol 49:576-80. 2014
    ..This is based on studies prior to the use of computerized tomography (CT) for confirmation of the diagnosis. We aimed to investigate the findings of a subsequent colonoscopy after an attack of uncomplicated diverticulitis...
  30. ncbi Overuse of acid suppressant drugs in patients with chronic renal failure
    Hans Strid
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Goteborg, Sweden
    Nephrol Dial Transplant 18:570-5. 2003
    ..The use of acid suppressive therapy (AST) in these patients is unexplored. We assessed the use of and indication for AST in CRF patients and compared them with hospitalized patients and patients with another chronic disease...